Neurofibromatosis type 1 From diagnosis to follow-up

被引:0
作者
Anders, Rebecca [1 ]
Hirsch, Franz Wolfgang [1 ]
Roth, Christian [1 ]
机构
[1] Univ Klinikum Leipzig, Inst Kinderradiol, Liebigstr 20a, D-04103 Leipzig, Germany
来源
RADIOLOGIE | 2022年 / 62卷 / 12期
关键词
Optic glioma; Neurofibroma; Genetic predisposition; Magnetic resonance imaging; Recommendations; OPTIC PATHWAY GLIOMAS; EVOLUTION; CHILDREN; MRI; NF1;
D O I
10.1007/s00117-022-01059-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome and is one of the most common genetic diseases. It is therefore a condition encountered by radiologists in clinical routine. Since the variability of the clinical expression is very high and several organ systems are affected, we present a standardized diagnostic approach in this article. Methods Evaluation of the literature on neurofibromatosis type 1 in the context of radiological examination methods. Results In addition to the frequently known changes in the central and peripheral nervous system such as optic gliomas and plexiform neurofibromas, lesions from the orthopedic spectrum and vascular changes must also be included in the radiological diagnosis. Conclusions Due to the diversity of the clinical picture of NF1, it is reasonable to define an examination strategy which takes into account the needs of radiological routine and also reliably detects the most frequent and prognostically significant pathologies accompanying this disease. In this article, the current recommendations for diagnosis of neurofibromatosis-associated tumors and skeletal changes are summarized, and examination protocols and time intervals are suggested.
引用
收藏
页码:1050 / 1057
页数:8
相关论文
共 38 条
[1]   Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis [J].
Ahlawat, Shivani ;
Blakeley, Jaishri O. ;
Langmead, Shannon ;
Belzberg, Allan J. ;
Fayad, Laura M. .
SKELETAL RADIOLOGY, 2020, 49 (02) :199-219
[2]   NEUROFIBROMATOSIS TYPE-1 AND TYPE-2 - CRANIAL MR FINDINGS [J].
AOKI, S ;
BARKOVICH, AJ ;
NISHIMURA, K ;
KJOS, BO ;
MACHIDA, T ;
COGEN, P ;
EDWARDS, M ;
NORMAN, D .
RADIOLOGY, 1989, 172 (02) :527-534
[3]   Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966 [J].
Bergqvist, Christina ;
Servy, Amandine ;
Valeyrie-Allanore, Laurence ;
Ferkal, Salah ;
Combemale, Patrick ;
Wolkenstein, Pierre ;
Adamski, Henri ;
Adamski, Henri ;
Baumann-Morel, Clarisse ;
Bellanne, Christine ;
Bieth, Eric ;
Bousquet, Pascal ;
Brandt, Christian ;
Balguerie, Xavier ;
Barbarot, Sebastien ;
Castelnau, Pierre ;
Chaix, Yves ;
Chevrant-Breton, Jacqueline ;
Collet, Evelyne ;
Cuny, Jean-Francois ;
Chastagner, Pascal ;
Chandeclerc, Marie-Lorraine ;
Cheuret, Emmanuel ;
Cintas, Pascal ;
Dollfus, Helene ;
Derancourt, Christian ;
Drouin-Garraud, Valerie ;
D'Incan, Michel ;
De Leersnyder, Helene ;
Dereure, Olivier ;
Doumar, Diane ;
Fabre, Nicolas ;
Ferraro, Vincenza ;
Francannet, Christine ;
Faivre, Laurence ;
Fellmann, Florence ;
Gaillard, Nathalie Feugier Dominique ;
Goldenberg, Alice ;
Guyant-Marechal, Lucie ;
Guillot, Bernard ;
Guillamo, Jean-Sebastien ;
Hadj-Rabia, Smail ;
Hamel-Teillac, Dominique ;
Kemlin, Isabelle ;
Lacour, Jean-Philippe ;
Laithier, Veronique ;
Lesavre, Nathalie ;
Lyonnet, Stanislas ;
Maincent, Kim ;
Maradeix, Sophie .
ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
[4]   Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI [J].
Calvez, S. ;
Levy, R. ;
Calvez, R. ;
Roux, C. -J. ;
Grevent, D. ;
Purcell, Y. ;
Beccaria, K. ;
Blauwblomme, T. ;
Grill, J. ;
Dufour, C. ;
Bourdeaut, F. ;
Doz, F. ;
Robert, M. P. ;
Boddaert, N. ;
Dangouloff-Ros, V. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2020, 41 (09) :1733-1739
[5]   Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours [J].
Cardona, S ;
Schwarzbach, M ;
Hinz, U ;
Dimitrakopoulou-Strauss, A ;
Attigah, N ;
Mechtersheimer, G ;
Lehnert, T .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (06) :536-541
[6]  
Cimino Patrick J, 2018, Handb Clin Neurol, V148, P799, DOI 10.1016/B978-0-444-64076-5.00051-X
[7]   Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision [J].
de Blank, Peter M. K. ;
Fisher, Michael J. ;
Liu, Grant T. ;
Gutmann, David H. ;
Listernick, Robert ;
Ferner, Rosalie E. ;
Avery, Robert A. .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2017, 37 :S23-S32
[8]   Skeletal Abnormalities in Neurofibromatosis Type 1: Approaches to Therapeutic Options [J].
Elefteriou, Florent ;
Kolanczyk, Mateusz ;
Schindeler, Aaron ;
Viskochil, David H. ;
Hock, Janet M. ;
Schorry, Elizabeth K. ;
Crawford, Alvin H. ;
Friedman, Jan M. ;
Little, David ;
Peltonen, Juha ;
Carey, John C. ;
Feldman, David ;
Yu, Xijie ;
Armstrong, Linlea ;
Birch, Patricia ;
Kendler, David L. ;
Mundlos, Stefan ;
Yang, Fen-Chun ;
Agiostratidou, Gina ;
Hunter-Schaedle, Kim ;
Stevenson, David A. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (10) :2327-2338
[9]   Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1 [J].
Filho, Jose Roberto Lopes Ferraz ;
Munis, Marcos Pontes ;
Souza, Antonio Soares ;
Sanches, Rafael Angelo ;
Goloni-Bertollo, Eni Maria ;
Pavarino-Bertelli, Erika Cristina .
PEDIATRIC RADIOLOGY, 2008, 38 (03) :305-310
[10]  
Friedrich RE, 2016, ANTICANCER RES, V36, P4095